Maxim sees buying opportunity for Catamaran, Express Scripts

theflyonthewall.com

Maxim believes concerns around private healthcare exchanges are overblown and sees buying opportunities for both Catamaran (CTRX) and Express Scripts (ESRX). The firm thinks pharmacy benefit managers will manage the drug benefit regardless of where employees get their insurance and keeps a Buy rating on both names. Maxim says Walgreen's move yesterday to a private exchange has furthered concerns that PBMs could face a decline in enrollment and negotiating power.

View Comments (0)